clarithromycin has been researched along with Bacterial Infections in 94 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (9.57) | 18.7374 |
1990's | 50 (53.19) | 18.2507 |
2000's | 23 (24.47) | 29.6817 |
2010's | 9 (9.57) | 24.3611 |
2020's | 3 (3.19) | 2.80 |
Authors | Studies |
---|---|
Agouridas, C; Bonnefoy, A; Bonnet, A; Bretin, F; Denis, A; Fromentin, C; Piltan, G | 1 |
Alihodzić, S; Andreotti, D; Berge, JM; Cipcić Paljetak, H; Derek, M; Dumić, M; Eraković Haber, V; Fajdetić, A; Holmes, DJ; Hutinec, A; Lazarevski, G; Lociuro, S; Marsić, N; Mutak, S; Spaventi, R; Stimac, V; Sunjić, V | 1 |
Almayah, AA; Bolandnazar, Z; Ebrahimi, A; Ebrahimi, HP; Hadi, JS; Swadi, AG | 1 |
Bertrand, D; Fernandes, P; Pereira, D; Watkins, PB | 1 |
Chen, X; Cheng, Y; Dai, Q; Lin, H; Liu, G; Ma, X; Pang, X; Xie, L; Yan, X; Ye, J; Zhang, X; Zhao, Q | 1 |
Agius, JE; Emery, JP; Phalen, DN; Rose, K | 1 |
Shibayama, K; Tsutsui, A; Yahara, K | 1 |
Abebe, W; Moges, F; Molla, R; Tiruneh, M | 1 |
Amighi, K; De Bueger, V; Pilcer, G; Sebti, T; Traina, K; Traore, H; Vanderbist, F | 1 |
Baconnet, B; Léophonte, P; Perronne, C; Zuck, P | 1 |
Benden, C; Boehler, A | 1 |
Alexander, RE; Grogan, DM | 1 |
Frydendall, N; Gluud, C; Hansen, JF; Hilden, J; Jespersen, CM; Kolmos, HJ | 1 |
Bono, BR; Qamar, F; Zuckerman, JM | 1 |
Hasan, SM; Hassan, F; Khan, NW; Naqvi, BS | 1 |
Lindeboom, JA | 1 |
Baranowski, WJ | 1 |
Weiss, LR | 1 |
Freudenstein, J; Hauke, W; Henneicke-Von Zepelin, HH; Köhler, G | 1 |
Blum, S; Sauter, C | 1 |
Busman, T; Dobryniewska, M; Nalepa, P; Notario, G | 1 |
Zuckerman, JM | 2 |
Gotfried, MH | 1 |
Miravitlles, M; Torres, A | 1 |
Eller, J; Ioanas, M; Linnhoff, A; Lode, H | 1 |
Ebisawa, K; Ishida, H; Kakoi, H; Kure, H; Kure, M; Saitoh, H; Takemura, Y | 1 |
Ariyürek, M; Doğru, D; Firat, P; Göçmen, A; Gürcan, N; Kiper, N; Mocan, G; Ozçelik, U; Sahin, A; Yalçin, E | 1 |
Altraja, A; Kullamaa, A; Leesik, H; Meriste, S; Naaber, P; Tamm, E | 1 |
Ferekidis, E; Maragoudakis, P; Nikolopoulos, TP; Tzagaroulakis, A; Vlastarakos, PV | 1 |
Abruzzo, GK; Bartizal, K; Flattery, AM; Gill, CJ; Jackson, J; Kong, L; Kropp, H; Shankaran, K; Smith, JG; Wilkening, R | 1 |
Burnham, LB; Citron, DM; Goldstein, EJ; Inderlied, CB; Kenner, MA | 1 |
Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
Calì, G; Consoli, G; Rossetti, B; Valenti, D | 1 |
Schlossberg, D | 1 |
Akita, H; Aoyama, T; Fujii, R; Iwata, S; Meguro, H; Satoh, Y; Sunakawa, K; Takeuchi, Y; Terashima, I; Yokota, T | 1 |
Barza, M; Eisenberg, E | 1 |
Parent, M | 1 |
Rodriguez, WJ; Wiedermann, BL | 1 |
Demartini, G; Fraschini, F; Scaglione, F | 1 |
Dubois, J; Saint-Pierre, C; Tremblay, C | 1 |
Narita, N | 1 |
Vetter, N; Waardenburg, FA; Wettengel, R | 1 |
Coles, SJ; James, I; Kearsley, NJ; Macklin, JL | 1 |
Holdcroft, C | 1 |
Hammerschlag, MR | 1 |
Müller, O | 1 |
Bradbury, F | 1 |
Hosie, J; Quinn, P; Sides, G; Smits, P | 1 |
Klein, JO | 1 |
Nightingale, CH | 1 |
Block, SL; Harris, J; Kolokathis, A; Tarlow, MJ | 1 |
Vagliasindi, M | 1 |
Deguchi, K; Fukumoto, T; Ishihara, R; Ishii, Y; Matsumoto, Y; Nakane, Y; Nakazawa, A; Nishinari, C; Suzuki, Y | 1 |
Appelbaum, PC; Ednie, LM; Jacobs, MR | 1 |
Felmingham, D; Grüneberg, RN; Harding, I; Robbins, MJ; Shrimpton, S; Tesfaslasie, Y | 1 |
Wiedermann, BL | 1 |
Gangadharam, PR | 1 |
Esposito, S; Principi, N | 1 |
Adelglass, J; Henry, DC; Jablonski, CK; Moller, DJ; Scheld, WM; Talbot, GH; Zhang, H | 1 |
Clifford, K; Echols, RM; Heyd, A; Huck, W; Shan, M; Tosiello, R | 1 |
Anzueto, A; Grossman, RF; Rizzo, JA | 1 |
Furunishi, M; Kita, E; Maeda, K; Mashima, T; Mikasa, K; Narita, N; Sakamoto, M; Ueta, K | 1 |
Citron, DM; Goldstein, EJ; Merriam, CV; Tyrrell, K; Warren, Y | 1 |
Adam, D; Brueckner, OJ; Glaser-Caldow, E; Hein, J; Hirsch, J; Kroemer, B; Wachter, J | 1 |
Prescott, LM | 1 |
McCarty, JM; Pierce, PF | 1 |
Neu, HC | 1 |
Danziger, LH; Piscitelli, SC; Rodvold, KA | 1 |
Tunkel, AR; Whitman, MS | 1 |
Clissold, SP; Peters, DH | 1 |
Craft, JC; Guay, DR | 1 |
Chonmaitree, T; Hedgpeth, D; Horlick, D; Howie, VM; Owen, MJ; Patel, JA | 1 |
Poirier, R | 1 |
Aldons, PM | 1 |
Anderson, G; Carnegie, C; Coles, S; Esmonde, TS; Macklin, J | 1 |
Bachand, RT | 1 |
Acar, J; Baquero, F; Bergan, T; Forsgren, A; Phillips, I; Wiedemann, B | 1 |
Gooch, G; Ho, D; Rolston, K | 1 |
Kawahira, M; Kobayashi, H; Miura, H; Nakaike, S; Otomo, S; Takeda, H | 1 |
Abe, T; Arimasu, O; Fujii, R; Higa, A; Hiruma, F; Meguro, H; Shinozaki, T; Sugamata, K; Sugie, N | 1 |
Akita, H; Iwata, S; Sato, Y; Sunakawa, K | 1 |
Matsumoto, K; Nakanishi, Y; Nakazawa, S; Narita, A; Niino, K; Sato, H; Suzuki, H | 1 |
Aramaki, M; Fujimoto, T; Kawakami, A; Koga, T; Kuroiwa, Y; Motohiro, T; Oda, K; Sakata, Y; Shimada, Y; Tanaka, K | 1 |
Abe, T; Arimasu, O; Fujii, R; Higa, A; Hiruma, F; Meguro, H; Shinozaki, T; Sugamata, K; Sugie, N; Sunagawa, K | 1 |
Ikeshima, K; Morihana, T; Morishima, T; Noma, H; Sakamoto, H; Sasaki, J; Shiiki, K; Takai, H; Tomita, F; Uematsu, M | 1 |
Bailer, R; Bower, RR; Fernandes, PB; Gade, E; Hanson, CW; Hardy, D; McDonald, E; Ramer, N; Shipkowitz, N; Swanson, R | 1 |
21 review(s) available for clarithromycin and Bacterial Infections
Article | Year |
---|---|
Long-acting erythromycins: assessing their role in treating outpatient odontogenic infections.
Topics: Ambulatory Care; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Clarithromycin; Delayed-Action Preparations; Erythromycin; Humans; Tooth Diseases | 2009 |
Macrolides, ketolides, and glycylcyclines: azithromycin, clarithromycin, telithromycin, tigecycline.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Clarithromycin; Humans; Ketolides; Macrolides; Minocycline; Tetracyclines; Tigecycline | 2009 |
Macrolides and ketolides: azithromycin, clarithromycin, telithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Clarithromycin; Humans; Ketolides; Macrolides | 2004 |
Clarithromycin (Biaxin) extended-release tablet: a therapeutic review.
Topics: Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Clarithromycin; Community-Acquired Infections; Delayed-Action Preparations; Humans; Tablets | 2003 |
Biofilms in ear, nose, and throat infections: how important are they?
Topics: Anti-Bacterial Agents; Bacterial Infections; Biofilms; Chronic Disease; Clarithromycin; Cochlear Implants; Combined Modality Therapy; Erythromycin; Foreign Bodies; Humans; Middle Ear Ventilation; Otitis Media with Effusion; Pharynx; Phenotype; Prosthesis-Related Infections; Sinusitis | 2007 |
Azithromycin and clarithromycin.
Topics: Azithromycin; Bacterial Infections; Clarithromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests | 1995 |
Azithromycin and clarithromycin.
Topics: Animals; Azithromycin; Bacterial Infections; Biological Availability; Clarithromycin; Drug Interactions; Half-Life; Humans; Microbial Sensitivity Tests; Tissue Distribution | 1994 |
The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Child; Clarithromycin; Fluoroquinolones; Humans | 1994 |
Clarithromycin clinical pharmacokinetics.
Topics: Absorption; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Biological Availability; Child; Clarithromycin; Drug Interactions; Drug Tolerance; Humans; Middle Aged | 1993 |
[Recent progress on diagnosis and therapy of diffuse panbronchiolitis].
Topics: Adult; Aged; Bacterial Infections; Bronchiolitis; Clarithromycin; Erythromycin; Female; Humans; Male; Middle Aged | 1993 |
Azithromycin and clarithromycin.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Clarithromycin; Erythromycin; Humans; Microbial Sensitivity Tests | 1993 |
History of macrolide use in pediatrics.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Drug Interactions; Erythromycin; Haemophilus Infections; Haemophilus influenzae; History, 20th Century; Humans; Infant; Infant, Newborn; Microscopy, Electron; Phagocytes; Phagocytosis | 1997 |
Pharmacokinetics and pharmacodynamics of newer macrolides.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Ear, Middle; Haemophilus Infections; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Streptococcal Infections; Tissue Distribution | 1997 |
Future indications for macrolides.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Helicobacter Infections; Humans; Malaria; Mycobacterium avium-intracellulare Infection; Pneumonia, Bacterial | 1997 |
Macrolides: clarithromycin and azithromycin.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Gastrointestinal Diseases; Humans; Male | 1998 |
Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Child; Clarithromycin; Drug Hypersensitivity; Drug Interactions; Erythromycin; Humans; Liver Function Tests | 1999 |
[Clinical application of the new action of macrolide preparations to respiratory diseases].
Topics: Anti-Bacterial Agents; Bacterial Infections; Bronchiectasis; Bronchitis; Chronic Disease; Clarithromycin; Erythromycin; Humans; Immunologic Factors; Lung Neoplasms | 1999 |
The newer macrolides: azithromycin and clarithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Clarithromycin; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans | 2000 |
Clarithromycin and azithromycin: new macrolide antibiotics.
Topics: Azithromycin; Bacterial Infections; Clarithromycin; Drug Interactions; Drug Labeling; Drug Resistance, Microbial; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria | 1992 |
Azithromycin and clarithromycin: overview and comparison with erythromycin.
Topics: Azithromycin; Bacterial Infections; Clarithromycin; Erythromycin; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Mycobacterium Infections, Nontuberculous; Respiratory Tract Infections; Sexually Transmitted Diseases; Skin Diseases, Infectious | 1992 |
Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.
Topics: Aged; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant | 1992 |
29 trial(s) available for clarithromycin and Bacterial Infections
Article | Year |
---|---|
Compliance with and short-term adverse events from clarithromycin versus placebo in patients with stable coronary heart disease: the CLARICOR trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Coronary Disease; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Patient Compliance; Placebos; Young Adult | 2009 |
Conservative wait-and-see therapy versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children.
Topics: Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Face; Female; Humans; Infant; Lymphadenitis; Male; Neck; Rifabutin; Time Factors; Treatment Outcome | 2011 |
Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bronchitis, Chronic; Cefuroxime; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome | 2002 |
Esberitox N as supportive therapy when providing standard antibiotic treatment in subjects with a severe bacterial infection (acute exacerbation of chronic bronchitis). A multicentric, prospective, double-blind, placebo-controlled study.
Topics: Adjuvants, Immunologic; Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Bronchitis, Chronic; Chronic Disease; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Humans; Lung Diseases, Obstructive; Pilot Projects; Plant Extracts; Roxithromycin; Time Factors | 2002 |
Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
Topics: Acute Disease; Adult; Aged; Analysis of Variance; Anti-Bacterial Agents; Bacterial Infections; Bronchitis, Chronic; Clarithromycin; Delayed-Action Preparations; Double-Blind Method; Drug Resistance, Bacterial; Humans; Middle Aged; Patient Compliance; Treatment Outcome | 2003 |
Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Disease Progression; Double-Blind Method; Female; Germany; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Statistics, Nonparametric; Treatment Outcome | 2004 |
Antibiotic selection patterns in acutely febrile new outpatients with or without immediate testing for C reactive protein and leucocyte count.
Topics: Acute Disease; Adult; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Biomarkers; C-Reactive Protein; Cephalosporins; Clarithromycin; Fever; Humans; Japan; Leukocyte Count; Middle Aged; Outpatient Clinics, Hospital; Practice Patterns, Physicians'; Respiratory Tract Infections; Treatment Outcome | 2005 |
Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis.
Topics: Adolescent; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bronchiectasis; Bronchoalveolar Lavage Fluid; Child; Clarithromycin; Colony Count, Microbial; Female; Humans; Interleukin-10; Interleukin-8; Leukocyte Count; Male; Respiratory Function Tests; Sputum; Tumor Necrosis Factor-alpha | 2006 |
[Clinical studies on clarithromycin dry syrup in the pediatric field. Pediatric Study Group of TE-031 Dry Syrup].
Topics: Administration, Oral; Adolescent; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Dosage Forms; Female; Humans; Infant; Intestinal Absorption; Male | 1994 |
Efficacy of clarithromycin vs. amoxicillin/clavulanate in the treatment of acute maxillary sinusitis.
Topics: Acute Disease; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Analysis of Variance; Bacterial Infections; Clarithromycin; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Male; Maxillary Sinusitis; Single-Blind Method; Treatment Outcome | 1993 |
Clarithromycin versus cefaclor for the treatment of mild-to-moderate acute bacterial bronchitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Bronchitis; Cefaclor; Clarithromycin; Double-Blind Method; Female; Humans; Male; Middle Aged | 1993 |
A single-blind, randomised, comparative study of clarithromycin and amoxycillin suspensions in the treatment of children with lower respiratory tract infections.
Topics: Amoxicillin; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Female; Humans; Infant; Male; Respiratory Tract Infections; Single-Blind Method; Suspensions | 1993 |
Comparison of azithromycin versus clarithromycin in the treatment of patients with upper respiratory tract infections.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Child; Clarithromycin; Drug Administration Schedule; Erythromycin; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Otitis Media; Pharyngitis; Respiratory Tract Infections; Sinusitis; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1993 |
Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Bronchitis; Clarithromycin; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia; Respiratory Tract Infections | 1993 |
A comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Chronic Disease; Clarithromycin; Erythromycin; Female; Humans; Macrolides; Male; Middle Aged; Patient Compliance; Single-Blind Method | 1995 |
Use of flurythromycin ethylsuccinate in infections of lower airways due to sensitive germs: multicenter comparative study with clarithromycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clarithromycin; Culture Media; Double-Blind Method; Erythromycin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Reference Standards; Respiratory Tract Infections | 1997 |
Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis. Sparfloxacin Multicenter AMS Study Group.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Maxillary Sinusitis | 1999 |
Double-blind comparative trial of ciprofloxacin versus clarithromycin in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Clarithromycin; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Maxillary Sinusitis; Middle Aged; Prospective Studies; Recurrence; Treatment Outcome | 1999 |
Comparative efficacy of clarithromycin modified-release and clarithromycin immediate-release formulations in the treatment of lower respiratory tract infection.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Chemistry, Pharmaceutical; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Respiratory Tract Infections; Treatment Outcome | 2001 |
Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Bronchitis, Chronic; Cefprozil; Cephalosporins; Clarithromycin; Demography; Double-Blind Method; Drug Administration Schedule; Humans; Microbial Sensitivity Tests; Middle Aged; Recurrence; Treatment Outcome | 2001 |
Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.
Topics: Aged; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant | 1992 |
Comparative safety and efficacy of clarithromycin and ampicillin in the treatment of out-patients with acute bacterial exacerbation of chronic bronchitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Ampicillin; Bacterial Infections; Bronchitis; Chi-Square Distribution; Chronic Disease; Clarithromycin; Erythromycin; Female; Humans; Male; Middle Aged; Recurrence; Treatment Outcome | 1992 |
Effect of viral respiratory tract infection on outcome of acute otitis media.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cefpodoxime; Ceftizoxime; Clarithromycin; Clavulanic Acids; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Male; Otitis Media; Respiratory Tract Infections; Treatment Outcome; Virus Diseases | 1992 |
Comparative study of clarithromycin and roxithromycin in the treatment of community-acquired pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Clarithromycin; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia; Remission Induction; Roxithromycin | 1991 |
A comparison of clarithromycin with ampicillin in the treatment of outpatients with acute bacterial exacerbation of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Ampicillin; Bacterial Infections; Bronchitis; Chronic Disease; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Middle Aged | 1991 |
A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia | 1991 |
Comparative study of clarithromycin and ampicillin in the treatment of patients with acute bacterial exacerbations of chronic bronchitis.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Bacterial Infections; Bronchitis; Chronic Disease; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Middle Aged; Remission Induction; Sputum | 1991 |
[Bacteriological, pharmacokinetic and clinical studies on clarithromycin in the pediatric field. Pediatric Study Group of Clarithromycin].
Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Microbial; Erythromycin; Female; Humans; Infant; Male; Multicenter Studies as Topic | 1989 |
[Clinical evaluation of clarithromycin in treatment of acute dental infections. Comparative double-blind study using josamycin as the control].
Topics: Acute Disease; Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Clarithromycin; Clinical Trials as Topic; Double-Blind Method; Drug Resistance, Microbial; Erythromycin; Female; Humans; Leucomycins; Male; Middle Aged; Multicenter Studies as Topic; Tooth Diseases | 1989 |
45 other study(ies) available for clarithromycin and Bacterial Infections
Article | Year |
---|---|
Beta-keto-ester chemistry and ketolides. Synthesis and antibacterial activity of 2-halogeno, 2-methyl and 2,3 enol-ether ketolides.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Macrolides; Mice; Structure-Activity Relationship | 2000 |
4''-O-(omega-Quinolylamino-alkylamino)propionyl derivatives of selected macrolides with the activity against the key erythromycin resistant respiratory pathogens.
Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Bacterial; Erythromycin; Humans; Macrolides; Microbial Sensitivity Tests; Propionates | 2010 |
Metal-based biologically active azoles and β-lactams derived from sulfa drugs.
Topics: Anti-Bacterial Agents; Azoles; Bacteria; Bacterial Infections; beta-Lactams; Coordination Complexes; Humans; Ligands; Microbial Sensitivity Tests; Models, Molecular; Schiff Bases; Sulfamethoxazole; Sulfathiazole; Sulfathiazoles | 2016 |
Differentiating the Pharmacodynamics and Toxicology of Macrolide and Ketolide Antibiotics.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Bacterial; Drug-Related Side Effects and Adverse Reactions; Humans; Ketolides; Macrolides | 2020 |
Photoacoustic Imaging-Trackable Magnetic Microswimmers for Pathogenic Bacterial Infection Treatment.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Drug Resistance, Multiple, Bacterial; Fluorescent Dyes; Indoles; Klebsiella pneumoniae; Magnetic Phenomena; Mice; Microbial Sensitivity Tests; Optical Imaging; Photoacoustic Techniques; Phototherapy; Polymers; Spirulina | 2020 |
Experimental infection of Asian house geckos with Enterococcus lacertideformus demonstrates multiple disease transmission routes and the in-vivo efficacy of antibiotics.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Disease Models, Animal; Enrofloxacin; Enterococcus; Humans; Lizards | 2021 |
Trends and patterns of national antimicrobial consumption in Japan from 2004 to 2016.
Topics: Administration, Oral; Amoxicillin; Anti-Infective Agents; Bacterial Infections; Ceftriaxone; Cephalosporins; Clarithromycin; Drug Utilization; Fluoroquinolones; Humans; Infusions, Parenteral; Japan; Macrolides; Product Surveillance, Postmarketing; Sulfamethoxazole; World Health Organization | 2018 |
Clarithromycin in patients with coronary artery disease.
Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Bacterial Infections; Clarithromycin; Coronary Artery Disease; Humans; Risk Factors | 2018 |
Bacterial profile and antimicrobial susceptibility patterns in chronic suppurative otitis media at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Chronic Disease; Ciprofloxacin; Clarithromycin; Ethiopia; Hospitals, Special; Hospitals, University; Humans; Microbial Sensitivity Tests; Norfloxacin; Otitis Media, Suppurative; Proteus mirabilis; Staphylococcus aureus | 2019 |
Carrier-free combination for dry powder inhalation of antibiotics in the treatment of lung infections in cystic fibrosis.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Crystallization; Cystic Fibrosis; Drug Combinations; Drug Compounding; Drug Synergism; Dry Powder Inhalers; Lung; Lung Diseases; Microscopy, Electron, Scanning; Particle Size; Powders; Tissue Distribution; Tobramycin; X-Ray Diffraction | 2013 |
[Routine use of extended-release clarithromycin tablets for short-course treatment of acute exacerbations of non-severe COPD].
Topics: Administration, Oral; Adult; Aged; Bacterial Infections; Child; Clarithromycin; Delayed-Action Preparations; Disease Progression; Drug Tolerance; Female; France; Humans; Middle Aged; Physicians, Family; Pulmonary Disease, Chronic Obstructive; Rural Population; Smoking; Urban Population | 2008 |
Long-term clarithromycin therapy in the management of lung transplant recipients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Bronchiolitis Obliterans; Child; Clarithromycin; Drug Administration Schedule; Female; Forced Expiratory Volume; Humans; Lung Diseases; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Young Adult | 2009 |
Antimicrobial activity of erythromycin and clarithromycin against clinical isolates of Escherichia coli, Staphylococcus aureus, Klebsiella and Proteus by disc diffusion method.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clarithromycin; Diffusion; Erythromycin; Escherichia coli; Humans; Klebsiella; Microbial Sensitivity Tests; Proteus; Staphylococcus aureus | 2011 |
Clarithromycin-induced hypersomnia in children.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Child, Preschool; Clarithromycin; Disorders of Excessive Somnolence; Female; Humans; Male; Narcolepsy | 2011 |
Antibiotics for heart health?
Topics: Anti-Bacterial Agents; Bacterial Infections; Chest Pain; Clarithromycin; Coronary Artery Disease; Humans; Inflammation | 2002 |
Regression of lung lesions in Hodgkin's disease by antibiotics: case report and hypothesis on the etiology of Hodgkin's disease.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Clarithromycin; DNA, Bacterial; Female; Hodgkin Disease; Humans; Lung Neoplasms; Reed-Sternberg Cells | 2003 |
[Fluoroquinolone superior to macrolide. Longer infection free period after acute bronchitis].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Bronchitis; Clarithromycin; Double-Blind Method; Follow-Up Studies; Humans; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Recurrence | 2003 |
Antibiotics in exacerbations of COPD: lessons from the past.
Topics: Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Disease Progression; Humans; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic | 2004 |
Antimicrobial susceptibility of common pathogens from community-acquired lower respiratory tract infections in Estonia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefuroxime; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Community-Acquired Infections; Drug Resistance, Bacterial; Estonia; Female; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Respiratory Tract Infections; Streptococcus pneumoniae | 2006 |
In vivo evaluation of three acid-stable azalide compounds, L-701,677, L-708,299 and L-708,365 compared to erythromycin, azithromycin and clarithromycin.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Clarithromycin; Drug Evaluation, Preclinical; Drug Stability; Erythromycin; Female; Half-Life; Klebsiella Infections; Macrolides; Mice; Mice, Inbred DBA; Molecular Structure; Staphylococcal Infections; Streptococcal Infections | 1995 |
Activity of ampicillin/sulbactam, ticarcillin/clavulanate, clarithromycin, and eleven other antimicrobial agents against anaerobic bacteria isolated from infections in children.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroidaceae; Child; Clarithromycin; Clavulanic Acid; Clavulanic Acids; Clostridium; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Sulbactam; Ticarcillin | 1995 |
Susceptibilities of 201 anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin by oxyrase agar dilution and E test methodologies.
Topics: Agar; Azithromycin; Bacteria, Anaerobic; Bacterial Infections; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Evaluation Studies as Topic; Humans; Microbial Sensitivity Tests; Oxygenases; Roxithromycin | 1995 |
[Clarithromycin in the treatment of oral infections].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Clarithromycin; Drug Evaluation; Humans; Middle Aged; Mouth Diseases; Remission Induction; Tooth Diseases | 1994 |
[Initial empiric treatment of pneumonia and the new antibiotics].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxime; Cefuroxime; Clarithromycin; Fluoroquinolones; Humans; Pneumonia | 1994 |
Two new macrolide antibiotics: clarithromycin and azithromycin.
Topics: Azithromycin; Bacterial Infections; Clarithromycin; Drug Costs; Erythromycin; Humans | 1993 |
[Antimicrobial activities of clarithromycin against recent obtained clinical isolates].
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clarithromycin; Drug Resistance, Microbial; Humans; Time Factors | 1997 |
Anti-anaerobic activity of erythromycin, azithromycin and clarithromycin: effect of pH adjustment of media to compensate for pH shift caused by incubation in CO2.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria, Anaerobic; Bacterial Infections; Carbon Dioxide; Clarithromycin; Colony Count, Microbial; Culture Media; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Gram-Negative Bacteria; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Oxygenases | 1998 |
Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Cefaclor; Cephalosporins; Ciprofloxacin; Clarithromycin; Common Cold; Community-Acquired Infections; Dose-Response Relationship, Drug; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Multicenter Studies as Topic; Penicillins; Respiratory System; Respiratory Tract Infections; Streptococcus pneumoniae; United Kingdom | 1998 |
Clarithromycin for non-mycobacterial diseases?
Topics: Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Drug Resistance, Microbial; Humans; Mycobacterium Infections; Risk Assessment | 1998 |
The infection-free interval: its use in evaluating antimicrobial treatment of acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Bacterial Infections; Bronchitis; Cefuroxime; Ciprofloxacin; Clarithromycin; Humans; Time Factors | 1999 |
Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria, Anaerobic; Bacterial Infections; Clarithromycin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Roxithromycin | 1999 |
Macrolides, azalides, and streptogrammins.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteremia; Bacterial Infections; Clarithromycin; Clofazimine; Cryptosporidiosis; Drug Therapy, Combination; Duodenal Ulcer; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium-intracellulare Infection; Pneumonia; Smoking; Virginiamycin | 1996 |
New macrolide antibiotics: azithromycin and clarithromycin.
Topics: Animals; Azithromycin; Bacterial Infections; Clarithromycin; Erythromycin; Humans | 1992 |
Studies show new macrolide antibiotics to be superior to some older agents.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Clarithromycin; Drug Administration Schedule; Erythromycin; Fluoroquinolones; Humans; Quinolones | 1992 |
Two macrolide antimicrobials approved for marketing.
Topics: Azithromycin; Bacterial Infections; Clarithromycin; Erythromycin; Humans; United States; United States Food and Drug Administration | 1992 |
Clarithromycin and azithromycin.
Topics: Azithromycin; Bacterial Infections; Clarithromycin; Clinical Trials as Topic; Erythromycin; Humans; Microbial Sensitivity Tests | 1992 |
Clinical results using two new antibiotics--clarithromycin and temafloxacin.
Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Bacterial Infections; Clarithromycin; Erythromycin; Fluoroquinolones; Humans; Opportunistic Infections; Quinolones | 1991 |
ESGAB breakpoint determination: clarithromycin.
Topics: Bacteria; Bacterial Infections; Clarithromycin; Erythromycin; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Mycoplasma pneumoniae | 1991 |
In-vitro activity of clarithromycin (A-56268; TE-031) against gram-positive bacteria.
Topics: Bacterial Infections; Clarithromycin; Erythromycin; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Neoplasms | 1989 |
[Long-term administration study on TE-031 (A-56268) in the treatment of diffuse panbronchiolitis].
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Bronchitis; Clarithromycin; Erythromycin; Female; Humans; Killer Cells, Natural; Male; Middle Aged; Time Factors | 1989 |
[Clinical evaluation of clarithromycin, a new macrolide antibiotic in children].
Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Drug Evaluation; Drug Resistance, Microbial; Erythromycin; Female; Half-Life; Humans; Infant; Male | 1989 |
[Laboratory and clinical studies on clarithromycin in pediatrics].
Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Drug Evaluation; Drug Resistance, Microbial; Erythromycin; Female; Humans; Infant; Male; Respiratory Tract Infections | 1989 |
[Pharmacokinetic, bacteriological and clinical studies in the pediatric field on clarithromycin].
Topics: Age Factors; Bacteria; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Dosage Forms; Drug Evaluation; Drug Resistance, Microbial; Erythromycin; Female; Half-Life; Humans; Infant; Male | 1989 |
[Clinical study on clarithromycin granule and tablet in the field of pediatrics].
Topics: Age Factors; Bacteria; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Dosage Forms; Drug Evaluation; Drug Resistance, Microbial; Erythromycin; Female; Humans; Infant; Male | 1989 |
In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clarithromycin; Drug Combinations; Drug Synergism; Erythromycin; Female; Guinea Pigs; Humans; Hydrogen-Ion Concentration; Injections, Subcutaneous; Kinetics; Legionella; Legionnaires' Disease; Male; Mice; Microbial Sensitivity Tests; Sulfamethoxazole | 1986 |